DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lithium use and primary hyperparathyroidism.

Author(s): Broome JT, Solorzano CC

Affiliation(s): Division of Surgical Oncology and Endocrine Surgery, Department of Surgical Sciences, Vanderbilt University, Nashville, Tennessee 37232-6860, USA. james.broome@vanderbilt.edu

Publication date & source: 2011-03, Endocr Pract., 17 Suppl 1:31-5.

Publication type: Review

OBJECTIVE: To review suspected causes of lithium-induced hyperparathyroidism, disease presentation, underlying pathology, and current recommendations and trends in medical and surgical treatment. METHODS: Relevant literature was reviewed. RESULTS: Lithium carbonate therapy has continued to be a mainstay of treatment for bipolar disease and schizoaffective disorder since its introduction into clinical use. Several metabolic consequences are associated with its long-term use, including hypercalcemia and hyperparathyroidism. CONCLUSIONS: Until further data become available, the surgeon should remain vigilant for the presence of pathologically active glands that may manifest their function at different times during the disease course.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017